Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance

Published:2012-02 Issue:1-2 Volume:15 Page:70-80
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Shukla Suneet,Chen Zhe-Sheng,Ambudkar Suresh V.

Funder

NIH

St. John's University Seed

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference142 articles.

1. Low levels of ABCG2 expression in adult AML blast samples;Abbott;Blood,2002

2. Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux;Agarwal;J. Pharmacol. Exp. Ther.,2010

3. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance;Allikmets;Cancer Res.,1998

4. Fusion oncogenes in tumor development;Aman;Semin. Cancer Biol.,2005

5. Biochemical, cellular, and pharmacological aspects of the multidrug transporter;Ambudkar;Annu. Rev. Pharmacol. Toxicol.,1999

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent developments of P-glycoprotein inhibitors and its structure–activity relationship (SAR) studies;Bioorganic Chemistry;2024-02

2. A DNA/RNA heteroduplex oligonucleotide coupling asparagine depletion restricts FGFR2 fusion-driven intrahepatic cholangiocarcinoma;Molecular Therapy - Nucleic Acids;2023-12

3. Novel chlorin e6-based conjugates of tyrosine kinase inhibitors: Synthesis and photobiological evaluation as potent photosensitizers for photodynamic therapy;European Journal of Medicinal Chemistry;2023-12

4. Sweet Cherry Extract as Permeation Enhancer of Tyrosine Kinase Inhibitors: A Promising Prospective for Future Oral Anticancer Therapies;Pharmaceuticals;2023-10-27

5. Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy;2023-10-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3